Pharmakokinetik von Cannabidiol

Pharmakokinetik von Cannabidiol
Bioverfügbarkeit Oral: 13 -19% [1]
Inhaliert: 11-41% [2]
Halbwertszeit 18 -32 Stunden [3]
Quellen:
[1] Mechoulam R, Parker LA, Gallily R (November 2002). "Cannabidiol: an overview of some
pharmacological aspects". Journal of Clinical Pharmacology. 42 (11 Suppl): 11S–19S
[2] Scuderi C, Filippis DD, Iuvone T, Blasio A, Steardo A, Esposito G (May 2009). "Cannabidiol in
medicine: a review of its therapeutic potential in CNS disorders". Phytotherapy
Research (Review). 23 (5): 597–602.
[3] Devinsky, Orrin; Cilio, Maria Roberta; Cross, Helen; Fernandez-Ruiz, Javier; French,
Jacqueline; Hill, Charlotte; Katz, Russell; Di Marzo, Vincenzo; Jutras-Aswad, Didier; Notcutt, William
George; Martinez-Orgado, Jose; Robson, Philip J.; Rohrback, Brian G.; Thiele, Elizabeth; Whalley,
Benjamin; Friedman, Daniel (May 22, 2014). "Cannabidiol: Pharmacology and potential therapeutic role
in epilepsy and other neuropsychiatric disorders". Epilepsia. 55 (6): 791–802.